Patient selection criteria for Phase II trials are typically more stringent than for Phase I trials. Researchers look for patients with specific types of cancer who meet particular health and disease status criteria. This selective process helps ensure that the results are relevant to the target population and that the treatment is tested in the most appropriate group.
